Vitamin K2 Market Size & Share, by Type (MK-7, MK-4); Source (Natural, Synthetic); Application (Nutraceutical, Food, Pharmaceuticals); Form (Powder, Oil) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4278
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the Vitamin K2 Landscape

top-features-companies
    • Kappa Bioscience Group
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Gnosis by Lesaffre
    • Koninklijke DSM N.V
    • Pfizer Inc.
    • Viridis BioPharma Pvt. Ltd.
    • DuPont de Nemours, Inc.
    • Seebio Biotech (Shanghai) Co., Ltd.
    • GeneFerm Biotechnology Co., Ltd.
    • Kyowa Hakka Bio Co., Ltd.
    • International Flavors & Fragrances Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Kappa Bioscience invites Vitafoods to discuss vitamin K2 manufactured under the brand name K2Vital and its synergistic relationship with vitamin D.

  • Gnosis by Lesaffre expands its vitamin K2 offering by the acquisition of NattoPharma for global reach and to fuel new innovation for future of vitamin K2.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4278
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing vitamin k deficiency, and rising awareness regarding health amongst people are the major factors driving the growth of the vitamin K2 market.

The market is anticipated to attain a CAGR of ~26% over the forecast period, i.e., 2023-2035.

Regulations for nutraceuticals and issues related to expiry dates are estimated to hamper the market growth.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Kappa Bioscience Group, Gnosis by Lesaffre, Koninklijke DSM N.V., Viridis BioPharma Pvt. Ltd., DuPont, Seebio Biotech (Shanghai) Co., Ltd, Geneferm Biotechnology Co., Ltd., Kyowa Hakko Bio Co., Ltd, International Flavors & Fragrances Inc.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, source, application, and by region.

The nutraceuticals segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying